Previous studies have found that ELAVL1 is involved in the pathogenesis of Parkinson’s disease [37, 38], indicating the involvement of the ELAVL1 gene in the biological mechanism of neurodegeneration in MDD patients during m6A methylation. The gene discussed is ELAVL1; the disease is Parkinson disease.